CRISPR-Cas9-Mediated ELANE Mutation Correction in Hematopoietic Stem and Progenitor Cells to Treat Severe Congenital Neutropenia.
Mol Ther
; 28(12): 2621-2634, 2020 12 02.
Article
in En
| MEDLINE
| ID: mdl-32822592
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Genetic Therapy
/
Hematopoietic Stem Cell Transplantation
/
Leukocyte Elastase
/
CRISPR-Cas Systems
/
Congenital Bone Marrow Failure Syndromes
/
Mutation
/
Neutropenia
Limits:
Animals
/
Humans
Language:
En
Journal:
Mol Ther
Journal subject:
BIOLOGIA MOLECULAR
/
TERAPEUTICA
Year:
2020
Type:
Article
Affiliation country:
Germany